196 related articles for article (PubMed ID: 20082125)
1. In vitro degradation of insulin-like peptide 3 by insulin-degrading enzyme.
Zhang WJ; Luo X; Guo ZY
Protein J; 2010 Feb; 29(2):93-8. PubMed ID: 20082125
[TBL] [Abstract][Full Text] [Related]
2. Degradation of relaxin family peptides by insulin-degrading enzyme.
Bennett RG; Heimann DG; Hamel FG
Ann N Y Acad Sci; 2009 Apr; 1160():38-41. PubMed ID: 19416156
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
[TBL] [Abstract][Full Text] [Related]
4. Analogs of insulin-like peptide 3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivo.
Del Borgo MP; Hughes RA; Bathgate RAD; Lin F; Kawamura K; Wade JD
J Biol Chem; 2006 May; 281(19):13068-13074. PubMed ID: 16547350
[TBL] [Abstract][Full Text] [Related]
5. Recombinant expression of an insulin-like peptide 3 (INSL3) precursor and its enzymatic conversion to mature human INSL3.
Luo X; Bathgate RA; Liu YL; Shao XX; Wade JD; Guo ZY
FEBS J; 2009 Sep; 276(18):5203-11. PubMed ID: 19674100
[TBL] [Abstract][Full Text] [Related]
6. Insulin-degrading enzyme is capable of degrading receptor-bound insulin.
Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Amano K; Sakamoto T; Kawase Y; Akiyama H; Nagata M
Biochem Biophys Res Commun; 1988 Jan; 150(2):605-14. PubMed ID: 3277630
[TBL] [Abstract][Full Text] [Related]
7. Defining the LGR8 residues involved in binding insulin-like peptide 3.
Scott DJ; Wilkinson TN; Zhang S; Ferraro T; Wade JD; Tregear GW; Bathgate RA
Mol Endocrinol; 2007 Jul; 21(7):1699-712. PubMed ID: 17473281
[TBL] [Abstract][Full Text] [Related]
8. Insulin-degrading enzyme.
Authier F; Posner BI; Bergeron JJ
Clin Invest Med; 1996 Jun; 19(3):149-60. PubMed ID: 8724818
[TBL] [Abstract][Full Text] [Related]
9. Multiple allosteric sites are involved in the modulation of insulin-degrading-enzyme activity by somatostatin.
Tundo GR; Di Muzio E; Ciaccio C; Sbardella D; Di Pierro D; Polticelli F; Coletta M; Marini S
FEBS J; 2016 Oct; 283(20):3755-3770. PubMed ID: 27579517
[TBL] [Abstract][Full Text] [Related]
10. Formation of insulin fragments by insulin-degrading enzyme: the role of zinc(II) and cystine bridges.
Bellia F; Pietropaolo A; Grasso G
J Mass Spectrom; 2013 Feb; 48(2):135-40. PubMed ID: 23378084
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme.
Manolopoulou M; Guo Q; Malito E; Schilling AB; Tang WJ
J Biol Chem; 2009 May; 284(21):14177-88. PubMed ID: 19321446
[TBL] [Abstract][Full Text] [Related]
12. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.
Qiu WQ; Walsh DM; Ye Z; Vekrellis K; Zhang J; Podlisny MB; Rosner MR; Safavi A; Hersh LB; Selkoe DJ
J Biol Chem; 1998 Dec; 273(49):32730-8. PubMed ID: 9830016
[TBL] [Abstract][Full Text] [Related]
13. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.
Shen Y; Joachimiak A; Rosner MR; Tang WJ
Nature; 2006 Oct; 443(7113):870-4. PubMed ID: 17051221
[TBL] [Abstract][Full Text] [Related]
14. Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues.
Yfanti C; Mengele K; Gkazepis A; Weirich G; Giersig C; Kuo WL; Tang WJ; Rosner M; Schmitt M
Int J Mol Med; 2008 Oct; 22(4):421-31. PubMed ID: 18813847
[TBL] [Abstract][Full Text] [Related]
15. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
Duckworth WC; Bennett RG; Hamel FG
Biochem Biophys Res Commun; 1998 Mar; 244(2):390-4. PubMed ID: 9514933
[TBL] [Abstract][Full Text] [Related]
16. Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme.
Zhang Z; Liang WG; Bailey LJ; Tan YZ; Wei H; Wang A; Farcasanu M; Woods VA; McCord LA; Lee D; Shang W; Deprez-Poulain R; Deprez B; Liu DR; Koide A; Koide S; Kossiakoff AA; Li S; Carragher B; Potter CS; Tang WJ
Elife; 2018 Mar; 7():. PubMed ID: 29596046
[TBL] [Abstract][Full Text] [Related]
17. Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway.
Kuo WL; Gehm BD; Rosner MR
Mol Endocrinol; 1991 Oct; 5(10):1467-76. PubMed ID: 1775131
[TBL] [Abstract][Full Text] [Related]
18. Medium-Chain Length Fatty Acids Enhance Aβ Degradation by Affecting Insulin-Degrading Enzyme.
Mett J; Lauer AA; Janitschke D; Griebsch LV; Theiss EL; Grimm HS; Koivisto H; Tanila H; Hartmann T; Grimm MOW
Cells; 2021 Oct; 10(11):. PubMed ID: 34831163
[TBL] [Abstract][Full Text] [Related]
19. Degradation of insulin by insulin-degrading enzyme and biological characteristics of its fragments.
Yonezawa K; Yokono K; Yaso S; Hari J; Amano K; Kawase Y; Sakamoto T; Shii K; Imamura Y; Baba S
Endocrinology; 1986 May; 118(5):1989-96. PubMed ID: 3516656
[TBL] [Abstract][Full Text] [Related]
20. Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures.
Lynch JA; George AM; Eisenhauer PB; Conn K; Gao W; Carreras I; Wells JM; McKee A; Ullman MD; Fine RE
J Neurosci Res; 2006 May; 83(7):1262-70. PubMed ID: 16511862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
